TY  - RPRT
TI  - A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects.
AU  - Meixian Ou
AU  - Yulei Zhuang
AU  - Huijuan Zhu
AU  - Rong Song
AU  - Qian Chen
AU  - Lin Luo
AU  - Li Deng
AU  - Yun Liu
AU  - Wei Wang
AU  - Jingying Jia
AU  - Chen Yu
AU  - Yanmei Liu
PY  - 2026
DO  - 10.1016/j.clinthera.2026.06.002
UR  - https://pubmed.ncbi.nlm.nih.gov/42373389/
ID  - 42373389
ER  -